Min Young Lee

Prof. Dr. Min Young Lee


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
OHOnju Ham
Onju Ham
CLChang Youn Lee
Chang Youn Lee
RKRan Kim
Ran Kim
JLJihyun Lee
Jihyun Lee
SOSekyung Oh
Sekyung Oh
WCWoochul Chang
Woochul Chang
Osteoarthritis (OA) is a chronic, progressive, and irreversible degenerative joint disease. Conventional OA treatments often result in complications such as pain and limited activity. However, transplantation of mesenchymal stem cells (MSCs) has several beneficial effects such as paracrine effects, anti-inflammatory activity, and immunomodulatory capacity. In addition, MSCs can be differentiated into several cell types, including chondrocytes, osteocytes, endothelia, and adipocytes. Thus, transplantation of MSCs is a suggested therapeutic tool for treatment of OA. However, transplanted naïve MSCs can cause problems such as heterogeneous populations including differentiated MSCs and undifferentiated cells. To overcome this problem, new strategies for inducing differentiation of MSCs are needed. One possibility is the application of microRNA (miRNA) and small molecules, which regulate multiple molecular pathways and cellular processes such as differentiation. Here, we provide insight into possible strategies for cartilage regeneration by transplantation of differentiated MSCs to treat OA patients.

1 October 2015 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GHGeun Hye Hwang
Geun Hye Hwang
JRJung Min Ryu
Jung Min Ryu
YJYu Jin Jeon
Yu Jin Jeon
JCJoonhyeok Choi
Joonhyeok Choi
Ho Jae HanHo Jae Han
Ho Jae Han
MLMin Young Lee
Min Young Lee

1 October 2015 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YJYu Jin Jeon
Yu Jin Jeon
JKJoong Sun Kim
Joong Sun Kim
GHGeun Hye Hwang
Geun Hye Hwang
ZWZhexue Wu
Zhexue Wu
Ho Jae HanHo Jae Han
Ho Jae Han
MLMin Young Lee
Min Young Lee

24 April 2024 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
MCMu Seog Choe
Mu Seog Choe
HYHan Cheol Yeo
Han Cheol Yeo
JKJoong Sun Kim
Joong Sun Kim
JLJean Lee
Jean Lee
HLHae Jun Lee
Hae Jun Lee
MLMin Young Lee
Min Young Lee
Background: Cerebral organoids (COs) are the most advanced in vitro models that resemble the human brain. The use of COs as a model for Alzheimer’s disease (AD), as well as other brain diseases, has recently gained attention. This study aimed to develop a human AD CO model using normal human pluripotent stem cells (hPSCs) that recapitulates the pathological phenotypes of AD and to determine the usefulness of this model for drug screening. Methods: We established AD hPSC lines from normal hPSCs by introducing genes that harbor familial AD mutations, and the COs were generated using these hPSC lines. The pathological features of AD, including extensive amyloid-β (Aβ) accumulation, tauopathy, and neurodegeneration, were analyzed using enzyme-linked immunosorbent assay, Amylo-Glo staining, thioflavin-S staining, immunohistochemistry, Bielschowsky’s staining, and western blot analysis. Results: The AD COs exhibited extensive Aβ accumulation. The levels of paired helical filament tau and neurofibrillary tangle-like silver deposits were highly increased in the AD COs. The number of cells immunoreactive for cleaved caspase-3 was significantly increased in the AD COs. In addition, treatment of AD COs with BACE1 inhibitor IV, a β-secretase inhibitor, and compound E, a γ-secretase inhibitor, significantly attenuated the AD pathological features. Conclusion: Our model effectively recapitulates AD pathology. Hence, it is a valuable platform for understanding the mechanisms underlying AD pathogenesis and can be used to test the efficacy of anti-AD drugs.

25 October 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MCMu Seog Choe
Mu Seog Choe
JKJoong Sun Kim
Joong Sun Kim
HYHan Cheol Yeo
Han Cheol Yeo
CBChang Min Bae
Chang Min Bae
HHHo Jae Han
Ho Jae Han
MLMin Young Lee
Min Young Lee
Every year, hundreds of thousands of people die because of metastatic brain cancer. Most metastatic cancer research uses 2D cell culture or animal models, but they have a few limitations, such as difficulty reproducing human tissue structures. This study developed a simple 3D in vitro model to better replicate brain metastasis using human cancer cells and human embryonic stem cell‐derived cerebral organoids (metastatic brain cancer cerebral organoid [MBCCO]). The MBCCO model successfully reproduced metastatic cancer processes, including cell adhesion, proliferation, and migration, in addition to cell‐cell interactions. Using the MBCCO model, we demonstrated that lung‐specific X protein (LUNX) plays an important role in cell proliferation and migration or invasion. We also observed astrocyte accumulation around and their interaction with cancer cells through connexin 43 in the MBCCO model. We analyzed whether the MBCCO model can be used to screen drugs by measuring the effects of gefitinib, a well‐known anticancer agent. We also examined the toxicity of gefitinib using normal cerebral organoids (COs). Therefore, the MBCCO model is a powerful tool for modeling human metastatic brain cancer in vitro and can also be used to screen drugs.

22 February 2024 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
WCWonyoung Choi
Wonyoung Choi
MCMu Seog Choe
Mu Seog Choe
SKSu Min Kim
Su Min Kim
SKSo Jin Kim
So Jin Kim
JLJiyeon Lee
Jiyeon Lee
LKLark Kyun Kim
Lark Kyun Kim
Proneural genes play a crucial role in neuronal differentiation. However, our understanding of the regulatory mechanisms governing proneural genes during neuronal differentiation remains limited. RFX4, identified as a candidate regulator of proneural genes, has been reported to be associated with the development of neuropsychiatric disorders. To uncover the regulatory relationship, we utilized a combination of multi-omics data, including ATAC-seq, ChIP-seq, Hi-C, and RNA-seq, to identify RFX4 as an upstream regulator of proneural genes. We further validated the role of RFX4 using an in vitro model of neuronal differentiation with RFX4 knock-in and a CRISPR-Cas9 knock-out system. As a result, we found that RFX4 directly interacts with the promoters of POU3F2 and NEUROD1. Transcriptomic analysis revealed a set of genes associated with neuronal development, which are highly implicated in the development of neuropsychiatric disorders, including schizophrenia. Notably, ectopic expression of RFX4 can drive human embryonic stem cells toward a neuronal fate. Our results strongly indicate that RFX4 serves as a direct upstream regulator of proneural genes, a role that is essential for normal neuronal development. Impairments in RFX4 function could potentially be related to the development of various neuropsychiatric disorders. However, understanding the precise mechanisms by which the RFX4 gene influences the onset of neuropsychiatric disorders requires further investigation through human genetic studies.